Cell-free Tumor DNA in Head and Neck Cancer Patients

NCT03942380 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2021-09-21

No results posted yet for this study

Summary

This study investigates if head and neck squamous cell carcinoma can be tracked with cell-free tumor DNA, RNA or HPV-DNA, in blood samples from patients referred with suspicion of cancer, and if it can be used in detecting recurrence in patients already diagnosed and treated for head and neck squamous cell carcinoma.

Conditions

  • Head and Neck Cancer
  • Head and Neck Neoplasms
  • Head and Neck Squamous Cell Carcinoma
  • Oropharynx Cancer
  • Oropharynx Neoplasm
  • Oropharynx Carcinoma
  • Oral Cavity Cancer
  • Oral Cancer
  • Oral Neoplasm
  • Larynx Cancer
  • Larynx Carcinoma
  • Larynx Neoplasm
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Cancer
  • Nasopharynx Neoplasm
  • Hypopharynx Cancer
  • Hypopharynx Neoplasm
  • Hypopharynx Carcinoma
  • Sinonasal Carcinoma
  • Thyroid Carcinoma
  • Thyroid Cancer
  • Thyroid Neoplasms
  • Salivary Gland Cancer
  • Salivary Gland Neoplasms
  • Salivary Gland Carcinoma
  • Sinonasal Cancer
  • Sinonasal Neoplasm

Interventions

DIAGNOSTIC_TEST

Liquid biopsy

The intervention is a liquid biopsy as a blood sample taken in a peripheral vein. The blood samples are analyzed for cell free DNA, RNA and HPV-DNA

Sponsors & Collaborators

  • Copenhagen University Hospital, Denmark

    collaborator OTHER
  • Department of Otorhinolaryngology, Head and Neck Surgery and Audiology

    collaborator UNKNOWN
  • Christian von Buchwald

    lead OTHER

Principal Investigators

  • Christian Von Buchwald, MD, DMSc · Department of Otorhinolaryngology, Head and Neck Surgery and Audiology

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2025-02-01
Completion
2025-02-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03942380 on ClinicalTrials.gov